Effects of Traditional Chinese Medicine, Ekki-Youketsu-Fusei-Zai, on Human Peripheral Blood Lymphocytes In Vitro by Deng Hong et al.
Effects of Traditional Chinese Medicine,
Ekki-Youketsu-Fusei-Zai, on Human Peripheral
Blood Lymphocytes In Vitro
journal or
publication title
Journal of Saitama Medical School
volume 28
number 3
page range 125-130
year 2001-07-25
URL http://id.nii.ac.jp/1386/00000458/
Creative Commons : 表示 - 非営利 - 改変禁止
http://creativecommons.org/licenses/by-nc-nd/3.0/deed.ja
Effects of Traditional Chinese Medicine, Ekki-Youketsu-Fusei-Zai, 
on Human Peripheral Blood Lymphocytes In Vitro
Original
Hong Deng a, b, Kaori Nakajima a, Xinling Ma a, Kenichiro Hasumi a, 
Toshitaka Akatsuka b and Haruhisa Wagoc
a)TCM laboratory, Electro-Chemical and Cancer Institute, 5-45-6 Kokuryo, Chofu, Tokyo 182-0022, Japan, 
b)Department of Microbiology, Saitama Medical School, Moroyama, Iruma-gun, Saitama 350-0495, Japan, c)Laboratory 
of Immunology, Department of Medical Technology, Saitama Medical School Junior College, Moroyama, Iruma-gun, 
Saitama 350-0495, Japan
Abstract: The effect of Traditional Chinese Medicine (TCM), Ekki-Youketsu-Fusei-Zai (EYFZ), on human 
peripheral blood lymphocytes (PBL) was investigated in vitro. MTT assay showed that EYFZ could directly 
stimulate PBL to proliferate without mitogen. In addition, RT-PCR and ELISA revealed that though EYFZ induced 
the expression of interferon gamma (INF-) mRNA and the production of INF- in culture supernatant, it did 
not induce the experssion or the production of interleukin-2 (IL-2) or interleukin-4 (IL-4). Moreover, we also 
examined which kind of immunocyte was involved in the INF- production by EYFZ in culture supernatant by 
inhibition experiment with monoclonal antibodies. It was shown that the EYFZ induced the production of INF- 
by T cell subsets of CD4 and CD8 cells. Thus, these results suggest that EYFZ has some significant stimulating 
effects on proliferation of PBL and the induction of INF- by T cells subsets in human.
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Introduction
Many investigators have reported the efficacy 
of Traditional Chinese Medicine (TCM) through 
various pharmacological and biological studies, using 
in vivo and in vitro systems1-3). Ekki-Youketsu-Fusei-
Zai (EYFZ), one of the TCMs, is a mixture composed 
of six kinds of crude drugs, which have been used 
for enhancing the immunological functions of cancer 
patients in China. Our studies have shown that EYFZ 
has anti-tumor effects such as a life-prolonging effect, 
tumor-growth inhibition, increase of body weight, and 
enhancement of cytotoxicity of natural killer (NK) cells 
in tumor-bearing mice4). Also, our study showed that 
EYFZ could induce the morphological change, the 
expression and the production of interleukin-12 (IL-12) 
on macrophage-like cell line, J774.15).
However, the effects of EYFZ on human peripheral 
blood lymphocytes (PBL) have not been reported 
so far in vitro. Therefore, in this study, we first 
examined whether or not EYFZ could stimulate PBL to 
proliferate without mitogen, express cytokine mRNA 
such as interferon gamma (IFN-), interleukin-2 
(IL-2) or interleukin-4 (IL-4) and produce them 
in culture supernatant. Then, we performed an 
inhibition experiment using both anti-CD4 and anti-CD8 
monoclonal antibodies to determine the involvement of 
CD4 or CD8 T cells in cytokine production. 
Materials and Methods
Preparation of EYFZ EYFZ is a mixture composed 
of six kinds of crude drugs, as reported before4). The 
crude drugs were obtained from Tochimoto., Ltd., 
Osaka, and EYFZ was prepared as follows: A mixture of 
Astragali radix (10.0 g), Zizyphi fructus (5.0 g), Amomi 
semen (5.0 g), Angelicae radix (8.0 g), Cervi parvum 
cornu (5.0 g) and Rehmanniae radix (10.0 g) was added 
to 200 ml water and soaked for 20 min. Then, it was 
boiled for 30 min for extraction of effective substances, 
and the solution was centrifuged at 3000 rpm for 20 
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min. Finally, the supernatant was condensed to 43 
ml (1 g crude drug/ml) by heating evaporation, and 
diluted with distilled water to desired concentrations.
Effect of EYFZ on proliferation of human PBL 
in vitro Effect of EYFZ on proliferation of human PBL 
was examined by MTT assay6, 7). Ten ml of peripheral 
blood was drawn from healthy adult donors into a 
small glass tube with heparin, and diluted 1:2 with PBS. 
Cell suspensions were layered on a Ficoll Isopaque 
(1.077 g/ml, Immuno-Biological Laboratories Ltd.) and 
centrifuged at 2000 rpm for 30 min. Mononuclear cells 
were collected from the interphase and washed three 
times with PBS. The peripheral blood mononuclear cells 
were suspended in RPMI-1640 medium containing 10% 
fetal bovine serum (FBS), NaHCO3 (2.0 g/L), HEPES 
(1.0 g/L), L-glutamine (0.6 g/L), and kanamycin (0.25 
mg/L), and cell concentration was adjusted to 1106 
cells/ml. These cells were incubated in a 75 cm2 tissue 
culture flask (IWAKI Glass Co., Ltd.) for 2 hr at 37℃ in 
a 5 % CO2 incubator to allow adherence. Then, non-
adherent lymphocytes were gently collected, and cell 
concentration was adjusted to 5105 cells/ml. 100 l of 
cell susperention was put into each well of 96 well flat-
bottomed plate (IWAKI) with EYFZ (2000 g/ml, 400 
g/m, 200 g/ml), concanavalin A (ConA) (5 g/ml) 
(SIGMA CHEMICAL CO.) or culture medium alone, and 
incubated for 72 hr at 37 ℃ in a 5 % CO2 incubator. After 
incubation, the proliferation of PBL was examined by 
MTT assay: Each well received 10 l of MTT (SIGMA) 
solution (5 mg/ml) and incubated for 5 hr at 37 ℃ in a 5 % 
CO2 incubator, then 0.1 ml of 0.04 mol/L HCl-isopropanol 
was added and incubated for 24 hr at 37 ℃ in a 5 % CO2 
incubator and an absorbance at 570 nm was analysed 
spectrophotometrically.
Reverse transcription-polymerase chain reaction 
(RT-PCR) for IFN-, interleukin-2 (IL-2) and 
interleukin-4 (IL-4) mRNA expression Human 
PBL were cultured with either EYFZ (400 g/ml), 
ConA (5 g/ml) or culture medium alone in 25 cm2 
plastic culture flasks (IWAKI) for 72 hr at 37 ℃ in a 5% 
CO2 incubator. After incubation, cells (1  106 cells) 
were used for the preparation of RNA. Total RNA was 
purified using RNeasy Mini Kit (QIAGEN).
The first strand cDNA synthesis was performed 
by incubating 0.5 g of RNA in a total reaction 
volume of 20 l containing 1 mM dNTP mixture, 1 
mM oligo-(dT), 1x reaction buf fer for AMV reverse 
transcriptase, and 4 units (U) of AMV reverse 
transcriptase XL (Life Science) at 42 ℃ for 4 hr. The 
sequence of oligo-(dT) was 
5’-GCTCTAGATTTTTTTTTTTTTTTTTTTTTT-3’.
RT-PCR was performed by adding 1U Taq 
polymerase and 2 l each of 10 mM oligonucleotide 
primers as described below. The condition of RT-PCR 
was as follows: IFN- and IL-2, 45 sec at 94 ℃ , 45 sec at 
60 ℃ , 90sec at 72 ℃ for 35 cycles; IL-4, 70 sec at 94 ℃, 
70 sec at 60 ℃ , 115 sec at 72 ℃ for 35 cycles.
The following primers were used for RT-PCR:
IFN- sense,
5’-ATGAAATATACAAGTTATATCTTGGCTTT-3’;
antisense, 5’-GATGCTCTTCGACCTCGAAACAGCAT-3’. 
IL-2 sense, 5’-ATGTACAGGATACAACTCCTGTCTT-3’; 
antisense, 5’-GTCAGTGTTGAGATGATGCTTTGAC-3’. 
IL-4 sense, 5’-ATGGGTCTCACCTCCCAACTGCT-3’; 
antisense, 5’-CGAACACTTTGAATTTTCTCTCTCAT-3’.
Analysis of effect of EYFZ on production of IFN-, 
IL-2 and IL-4 by ELISA Human PBL were cultured 
under the same condition as described above for the 
analysis of production of IFN-, IL-2 and IL-4. After 72 
hr incubation, the culture supernatant was collected 
and stored at 80 ℃ until use. IFN-, IL-2 and IL-4 were 
measured by ELISA according to the manufacturer’s 
instruction (OptEIATM Human IFN-, IL-2 and IL-4 
Set, PHARMINGEN) to analyse the effect of EYFZ on 
the cytokine production of human PBL.
Analysis of lymphocyte subsets involved in IFN- 
production Human PBL were prepared in a similar way 
as described above, and adjusted to a cell concentration of 
5105 cells/ml. Then, the PBL were finally re-suspended 
in RPMI-1640 medium with or without anti-human CD4 
(clone H129.19, Pharmingen, Sandiego)(5 g/ml), anti-
human CD8 (clone 53-6.7,Pharmingen, Sandiego)(5 
g/ml) or both anti-human CD4 and anti-human CD8. 
These monoclonal antibodies were used in an inhibition 
experiment : For example, the activity of cytotoxic T 
lymphocytes was shown to be inhibited or blocked by 
anti-CD88). In parallel with this test, we also examined 
the effect of addition of EYFZ (400 g/ml) to those 
using each monoclonal antibody. In this experiment, 
the control received the PBL alone or with EYFZ. The 
cells in 0.2 ml volume per well were incubated using 
96 well flat-bottomed plate (IWAKI) for 72 hr at 37 ℃ in 
a 5 % CO2 incubator. Following incubation, the culture 
supernatant was collected and stored at 80 ℃ until use. 
Then, IFN- was similarly measured by ELISA method 
as described before to know the effect of monoclonal 
antibodies on the IFN- production with or without 
EYFZ.
Statistical analysis The data were statistically analysed 
based on the Student’s t test, and differences were 
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recognized significant with p value less than 0.05. Here, 
results were expressed as mean  standard deviation 
(SD).
Results
Effects of EYFZ on proliferation of human PBL 
in vitro Proliferation of human PBL was examined by 
MTT assay. Peripheral blood was drawn from healthy 
donors, and separated PBL were cultured with either 
EYFZ (2000 g/ml, 400 g/ml, 200 g/ml), ConA 
(5 g/ml) or culture medium alone in a 96 well flat-
bottomed plate. After 72 hr-incubation, the proliferation 
of PBL was measured by MTT assay. All samples 
were measured in triplicate and the experiment was 
performed 3 times. As shown in Fig. 1, EYFZ directly 
stimulated PBL to proliferate without any mitogen, 
and proliferative effect was almost the same as that 
of ConA. (P0.01 versus the culture medium alone 
control)
Effect of EYFZ on expression of IFN-, IL-2 
and IL-4 mRNA Expression of IFN-, IL-2 and IL-4 
mRNA of PBL was examined by RT-PCR. As shown 
in Fig. 2, after 72 hr-incubation, EYFZ (400 g/ml) 
induced expression of IFN- mRNA as compared with 
culture medium alone, but not expression of IL-2 and 
IL-4. ConA (5 g/ml), as a control, induced significant 
expression of IFN-, IL-2 and IL-4 mRNA more than in 
EYFZ addition or in culture medium alone. 
Effect of EYFZ on production of IFN-, IL-2 and 
IL-4 in a culture supernatant It was examined 
whether or not EYFZ would affect the IFN-, IL-2 
and IL-4 production by PBL. As shown in Fig.3, 
after 72 hr-incubation, EYFZ (400 g/ml) promoted 
significantly the production of INF- in culture 
supernatant of PBL as compared with that in the 
culture supernatant without EYFZ or ConA (P0.01), 
but did not promote IL-2 or IL-4 production. ConA 
significantly promoted the production of IFN-, IL-2 
and IL-4 higher than in EYFZ addition or in culture 
medium addition alone. 
Effect of anti-CD4 and anti-CD8 on IFN- 
production with or without EYFZ This experiment 
was performed to identify the lymphocyte subsets 
associated with INF- production by EYFZ. As shown 
in Fig. 4, though INF- was not found after 72hr 
culture in the absence of EYFZ, the addition of 
EYFZ promoted the INF- production. However, the 
production of INF- was inhibited by anti-CD4 or 
anti-CD8 monoclonal antibodies as compared to the 
addition of EYFZ without antibody. The presence 
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Fig. 2. Effect of Ekki-Youketsu-Fusei-Zai (EYFZ) on 
expression of IFN-, IL-2 and IL-4 mRNA Human PBL 
(5105 cells/ml) were cultured with EYFZ (400 g/ml), ConA 
(5 g/ml) or culture medium alone in 25 cm2 culture flask. 
After 72 hr incubation, RT-PCR analysis was performed to 
determine the expression of IFN-, IL-2 and IL-4 mRNA.
Fig. 1. Effect of Ekki-Youketsu-Fusei-Zai (EYFZ) on 
proliferation of human peripheral blood lymphocytes 
(PBL) in vitro. Human PBL (5105 cells/ml) were cultured 
with EYFZ (2000 g/ml, 400 g/ml, 200 g/ml), ConA 
(5 g/ml) or culture medium alone in 96 well flat-bottomed 
plate. After 72 hr incubation, the proliferation of lymphocytes 
was measured by MTT assay. Each column and vertical bar 
represents the mean  standard error of triplicates. (P  0.01 
by Student’s two tailed test) (control: culture medium without 
EYFZ or ConA)
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of both antibodies also strongly inhibited the INF- 
production, although this inhibition was not perfect.
Discussion
In the present study, we examined the effect of 
EYFZ on the proliferation and cytokine production 
of the human PBL. Results clearly showed that 
culturing with EYFZ exerted a statistically significant 
proliferative effect on PBL. This proliferative response 
of PBL was comparable to that of ConA. ConA has been 
used as the specific mitogen for T lymphocytes9,10). 
In our experiment, culturing with EYFZ plus ConA 
gave similar proliferative effect on PBL as EYFZ alone 
and ConA alone (data not shown). This suggests that 
both stimulated T lymphocytes and their effects were 
maximum.
It has been reported that all the stimuli that induce 
proliferation of T cells initiate the synthesis of IL-2 
and the formation of IL-2R on the cell surface11). In 
Fig. 4. Effect of anti-CD4 and anti-CD8 on IFN- production with or without EYFZ. The human PBL (5105 cells/ml) 
were suspended in RPMI-1640 medium with or without mouse monoclonal anti-human CD4, anti-human CD8, or both anti-human 
CD4 and anti-human CD8. 0.2 ml of cell suspension was put into each well of 96 well flat-bottomed plate with or without EYFZ 
(400 g/ml), and incubated for 72 hr at 37 ℃ in a 5 % CO2 incubator. After 72 hr incubation, ELISA analysis was used to determine 
production of IFN-. Each column and vertical bar represents the mean  standard error of triplicates.
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Fig. 3. Effect of Ekki-Youketsu-Fusei-Zai (EYFZ) on 
production of IFN-, IL-2 and IL-4 in culture supernatant. 
Human PBL were cultured the same conditions as RT-PCR for 
IFN-, IL-2 and IL-4 mRNA expression. After 72hr incubation, 
ELISA analysis was used to determine production of IFN-, 
IL-2 and IL-4. Values are mean  standard error of triplicates 
and represent one of three indepent experiments. (P0.01 by 
Student’s two-tailed test) 
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our experiment, RT-PCR and ELISA revealed that 
ConA induced the expression of IL-2 mRNA and the 
production of IL-2 in a culture medium, but EYFZ did 
not induce the expression or the production of IL-2. 
About reasons, we don’t know exactly now. Because the 
EYFZ is a mixture of six kinds of crude drugs and an 
effective component of each crude drug was not clearly 
demonstrated to induce cytokine production. However, 
some studies on some murine T cell clones and 
human PBL shows the stimulation of cell proliferation 
with monoclonal antibody12,13). Therefore, since the 
proliferative effect of EYFZ on human PBL is possibly 
due to the IL-2-indepentent pathway. We will study this 
possibility in the future.
In addition, we also examined the effects of EYFZ 
on both the expression of IFN-, IL-2 and IL-4 mRNA 
and the production of IFN-, IL-2 and IL-4 in culture 
supernatant. Results showed that EYFZ induced only 
the expression of IFN- mRNA and production of 
IFN- in culture supernatant. The expressions and 
productions of IL-2 or IL-4 were not observed in our 
experiment. As has already been demonstrated, helper 
T cells are classified into two subsets (Th1 and Th2) 
on the basis of the cytokines synthesized by T cells. 
Namely, Th1 cells secreting IL-2 and/or INF- causes 
the cellular immunity, whereas Th2 cells secreting 
IL-4, IL-5, IL-6 and/or IL-10 participate in the humoral 
immunity14). As our investigation using anti-CD4 
and anti-CD8 clearly showed that CD4 and CD8 
T cell subsets were at least associated with the 
IFN- production in the presence of EYFZ. There 
is one possibility that EYFZ contains some effective 
components to induce only IFN- from those T cells. 
The mechanism of only IFN- production by T cells 
with EYFZ will be needed to be elucidated in the 
future.
In conclusion, results of our studies suggest that 
EYFZ can stimulate the human PBL to proliferate, 
and induce the expression and production of IFN- by 
stimulating T cells subsets of CD4 and CD8 T cells. 
The effects of EYFZ on T cells of patients in vivo and 
in vitro need to be further pursued.
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　中国の伝統的漢方薬である「益気養血扶正剤」（オウ
ギ，ジュクジオウ，トウキ，ジュクシャ，タイソウ，ロ
クジョウの 6種類から構成される：以下EYFZと略す）
が抗腫瘍活性を示すことを，担癌マウスの延命効果，
NK活性促進並びにマクロファージ細胞株J774.1細胞
機能活性化から明らかにしたので，本研究では特にヒ
トの末梢血中のリンパ球機能に着目し，In vitro で 
EYFZがリンパ球機能にいかなる影響を及ぼすかにつ
いて追究した．最初に，分離した末梢血中のリンパ球
増殖に対する影響をMTTアッセイで調べた結果，
EYFZはマイトーゲンが存在していない条件下でも著
しくリンパ球の増殖を引き起こすことがわかった．さ
らに，リンパ球由来サイトカインであるインターロイ
キン2（IL-2），IL-4及びインターフェロン -（IFN-）
の産生に対するEYFZの影響をRT-PCR法並びにELISA
法によって検討した．その結果，EYFZは特に
INF−mRNAのみの誘導とIFN-のみの産生を引き起
こす効果のあることが判明した．このINF−がいかな
る種類のリンパ球由来したものかを同定するために，
抗CD4抗体と抗CD8抗体を用いて阻害実験を行った
結果，これらの抗体によってINF−の産生は阻害され
ることがわかった．以上の結果から，EYFZにはヒト
末梢血中のCD4あるいはCD8のTリンパ球を芽球化
すると同時に，INF−の産生を促進してTh1優位を引
き起こす結果細胞性免疫を高める効果のあることが強
く示唆された．
中国の伝統的漢方薬「益気養血扶正剤」がヒト末梢血中のリンパ球機能に及ぽす影響
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